The Belgrade Institute of Virology, Vaccines and Serum “Torlak” will officially start production of the Russian Sputnik V COVID-19 vaccine on Serbian soil on Friday, June 4th, the press service of Serbian Minister of Innovation and Technological Development Nenad Popovic, who also heads group parliamentary friendship with Russia, he told TASS on Wednesday.
“Production of the Sputnik V vaccine is starting at the Torlak Institute on Friday, June 4,” the minister’s press service told the press.
EXCLUSIVE: Products @ sputnikvaccine at the Torgol Institute resist in song 04. south of the kindergarten celebration celebration that would be attended by the highest level of Serbian and Russian citizens. I wish you victory! 🇷🇸🇷🇺 pic.twitter.com/ewlI1RGd6t
– Nenad Popović (@npopovicSNP) June 2, 2021
The minister wrote on Twitter that a gala ceremony would kick off vaccine production and be attended by senior officials from Serbia and Russia. “Together we win!” Popovic wrote on Twitter.
On May 19, Russia’s Gamaleya National Research Institute confirmed the quality of the Sputnik V test vaccine produced at the Torlak Institute in Belgrade. Moreover, he approved the production of Russian wine at the Serbian institute.
On February 3, Russian President Vladimir Putin and Serbian counterpart Aleksandar Vucic focused on a phone call to the production of Sputnik V in Serbia. After the talks, Vucic said Serbia, with the help of experts from Russia, would build equipment to produce the vaccine independently. Serbia is expected to start packing the Sputnik V vaccine first and then its full-scale production will be announced by the end of the year.
So far, the Pfizer, Sinopharm, AstraZeneca and Sputnik V vaccines are available to the public there. Serbian Ambassador to Russia Miroslav Lazanski said that about 85% of Serbs who had booked vaccination appointments preferred to be vaccinated with Sputnik V.